Here are four things to know about the company’s performance.
1. Philips posted €3.94 billion (an estimated $4.82 billion) in sales for the first quarter, down 2 percent from €4.03 billion (an estimated $4.93 billion) during the same period last year.
2. The company reported €1.53 billion (an estimated $1.87 billion) in sales for its diagnosis and treatment business segment, up 3 percent from €1.49 billion (an estimated $1.82 billion) during the first quarter of 2017.
3. Philips reported sales for its connected care and health informatics business segment remained constant at €663 million (an estimated $811.04 million) during the first quarter, compared to €732 million (an estimated $895.45 million) during the first quarter of 2017.
4. The company posted a net income from continuing operations of €94 million (an estimated $114.99 million), down 27 percent from €128 million (an estimated $156.58 million) one year prior.
More articles on health IT:
7 most interesting questions NIH Director Dr. Francis Collins answered during his Reddit AMA
In wake of WannaCry, NHS assessed 200 facilities on cybersecurity preparedness — None passed
‘The mind of a mathematician with the heart of a doctor’: athenahealth CTO Prakash Khot shares 4 thoughts on AI in healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
